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Introduction
Throughout history, humans have used plant extracts for 
production of bio-active secondary metabolites required in 
their medications. Over the centuries, the genus Euphorbia 
has been known to be toxic to humans and animals. In 
traditional Iranian and Chinese medicine Euphorbia is 
used as anti-tumor and for elimination of warts (1,2). 
Recently, different species of Euphorbia showed cytotoxic 
effects against some cancer cell lines including antitumor 
properties of Euphorbia prolifera on ovarian cancer (3,4), 
E. helioscopia on breast cancer lines (5), and E. guyoniana 
against kidney cell line HEK293 (6). The genus Euphorbia 
has also a high diversity in Iran and represents 97 species 
in the Flora Iranica areas from which 56 with 17 endemics 
are growing in Iran and E. kopetdaghi is one of them (7). 
E. kopetdaghi is restricted in the kopedagh (northeastern 
Iran, northwestern Afghanistan and south Turkmenistan 
(7). Recently, in a primary study by Ghanadian et al. 
on this plant, significant suppressive activity against 
PHA activated T-cell proliferation and oxidative burst 
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Implication for health policy/practice/research/medical education:
In the present study, we evaluated the cytotoxicity properties of E. kopetdaghi extract and its fractions on cancer cells of OVCAR3 
and EJ-138. The observed moderated toxicity of fractions indicated that this plant has the value of more phytochemical consideration 
to find possible anti-cancer lead compounds.
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Introduction: Over the centuries, the genus Euphorbia was known to be toxic to humans and 
animals. Recently, in a primary study significant suppressive activity against phytohemagglutinin 
activated T-cell proliferation has been reported from this plant. Therefore, this study was designed 
to evaluate the cytotoxic effects of different parts of E. kopetdaghi against cancer cell lines.
Methods: Filtration and in vacuo concentration resulted in a green gum which was subjected on 
silica gel CC (hexane/Acetone, 0→50) to several fractions: F1-F8. The inhibitory effects of obtained 
fractions with 5, 50, and 500 μg/ml concentrations were evaluated on proliferation and viability 
of cancer cells (OVCAR and EJ-138) in 48 hours treatment. Finally, cell viability was determined 
at a wavelength of 570 by 3-4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) 
method.
Results: Based on studies of microscopic observation and viability testing, F1, F2, F4, F5, F6, 
and F7 showed significant cytotoxic effect at concentration of 50 and 500 µg/ml against EJ-138 
and OVCAR-3 cell lines. These fractions inhibited growth of EJ-138 and OVCAR-3 cells in a 
concentration-dependent manner. Fraction of F8 induced tumor promotion significantly in EJ-
138 and OVCAR-3 cells, respectively.
Conclusion: Due to the inhibitory properties of E. kopetdaghi extract and its fractions on cancer 
cells of OVCAR3 and EJ-13, isolation, purification and identification of compounds presented 
in the fractions possessing cytotoxic effects are recommended which were the area of our future 
research.
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suppressive activity was reported (8). Therefore, this study 
was designed to evaluate the cytotoxic effects of different 
parts of E. kopetdaghi against two different cancer cell lines: 
Human ovarian carcinoma cancer cell line (OVCAR-3), 
and Human bladder carcinoma cancer cell line (EJ138).
Material and Methods
Plant material
The Euphorbia kopetdaghi was collected from Mashhad 
(Khorasan province, North East of Iran), in July 2013. The 
plant was authenticated by the Department of Forestry, 
University of Isfahan, Iran. The plant materials were 
stored at -20°C before use. A Voucher specimen no: 2024 
of the plant was deposited in the herbarium unit of the 
School of Pharmacy and Pharmaceutical Sciences, Isfahan 
University of Medical Sciences, Isfahan, Iran.
Extraction and isolation
Aerial parts of plant was extracted by ethylacetate. The 
extract was concentrated under reduced pressure at 
40–45°C by rotatory vacuum evaporator (Heidolph, 
Germany) and resulted in a green gum, which was charged 
over a cake of 15% paraffin impregnated silica-gel (400 
g) packed into a sintered Buchner funnel (150×90 mm) 
using MeOH: H2O (65:35) as eluent to remove fats and 
chlorophyl. The ungreased fraction lacked of its apolar 
constituents, was separated on silica gel CC (hexane/
acetone, 0→50). 
MTT viability assay
Human ovarian carcinoma cancer cell line OVCAR-3, 
and Human bladder carcinoma cancer cell line EJ138 
were obtained from Pasteur Institute of Iran. The cell 
lines were grown in RPMI-1640 media supplemented 
with 10% fetal calf serum, 100 U/ml + 100 µg/ml 
penicillin and streptomycin at 37°C in 5% CO2 condition. 
Cell viability was determined colorimetric assay, using 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) and compared with untreated controls 
(9). Cells were seeded at 5 × 103 cells/well in 96-well plates. 
After incubation, compounds at concentrations of 5, 50, 
and 500 µg/ml were added and incubated again for 48 
hours. Then, MTT (5 mg/ml in PBS) was added to each well 
and the cells were incubated for 4 hours. The supernatants 
were aspirated and 200 μl of dimethyl sulfoxide was added 
to each well. The plates were shaken for 10 minutes and 
using colorimetric method, the absorbance was read by 
the microplate reader (Bio-Rad, Hercules, CA, USA) at 
570 nm. Cell viability was calculated based on the formula: 
(mean OD of treated cells/mean OD of control cells) × 
100. The results expressed as percent of untreated cells.
The criteria used to categorize the cytotoxicity of isolated 
fractions against cancer cell lines, based on U.S. National 
Cancer Institute (NCI) and Geran protocol (10,11) was as 
follows: IC50 ≤ 20 µg/ml = highly cytotoxic, IC50 21-200 µg/
ml = moderately cytotoxic, IC50 201-500 µg/ml = weakly 
cytotoxic and IC50 > 501 µg/ml = no cytotoxic.
Statistical analysis
One-way analysis of variance (ANOVA) was performed 
using Dennett’s test as post hoc analysis. Each experiment 
was carried out in triplicate independently. P<0.05 
was considered significant. All data are expressed as 
means ± SD.
Results
The isolated fractions of column chromatography were 
concentrated by a rotary evaporator at 40° C and combined 
based on their TLC profile to afford 8 combined fractions 
which are displayed in Table 1. Fr 1-8 stored in refrigerator 
at -20°C before use.
To investigate the cytotoxic effects of different factions of 
the E. kopetdaghi, on the cell viability, EJ-138 and OVCAR 
cell lines were incubated with the concentrations of 5, 
50, and 500 μg/mL of fractions 1-8. After, 48 hours, cell 
cytotoxicity was evaluated using standard MTT assay. 
Fraction F2 showed significant cytotoxic effect (P<0.05) at 
lower concentration of 5, 50 and µg/ml against EJ-138 cell 
line. F1, F4, F5, F6, and F7 showed significant cytotoxic 
effect at concentrations of 50 and 500 µg/ml against EJ-
138 and OVCAR-3 cell lines. These fractions inhibited 
growth of EJ-138 and OVCAR-3 cells in a concentration-
dependent manner. 
Fraction F3 reduced tumor promotion significantly 
(P<0.05) at concentrations of 50 µg/ml but then slightly 
induced cell proliferation of viable cells at higher 
concentration of 500 µg/ml in both EJ-138 and OVCAR-3 
cells. Fraction F8 induced tumor promotion, significantly 
(P<0.05) by 288.5%± 34.2, and 134.9%± 15.4 in EJ-138 
and OVCAR-3 cells, respectively. Cytotoxicity activities of 
Fr 1-8 against cancer cell lines: EJ-138 and OVCAR-3 cells 
are displayed in Figure 1.
The IC50 was calculated for all of the fractions with 
cytotoxic activities (Table 2). Based on NCI and Geran 
protocol, Fractions F1, F2, F4, F5, F6 and F7 showed 
moderate cytotoxicity against OVCAR-3 and EJ-138 
cancer cell lines.
Discussion
Since triterpenoids along with macrocyclic diterpenoids 
are the main phytochemicals isolated from the genus 
Table 1. The solvent system employed for column chromatography
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Euphorbia (2), the observed cytotoxicity are mainly due 
to the presence of these compounds. None of the fractions 
showed high cytotoxic activity (IC50 < 20 µg/ml). 
Inspected by NMR, Fr. 1 and Fr. 2 with typical signals of 
triterpenoids showed more cytotoxic effects. Moderate 
cytotoxic activities observed by Fr. 4-Fr. 7 are probably 
due to the presence of diterpenoid polyesters reported 
in the genus Euphorbia. The induced cell proliferation 
of viable cells by Fr. 8 at higher concentrations in both 
EJ-138 and OVCAR-3 cells may be due to the presence 
of phorbol or ingenol esters which are known for their 
cancer promoting effects. 
Compared with literature, chloroform and ethyl acetate 
fractions of Euphorbia wallichi, as reported by Irshad Ali 
and co-workers, showed moderate cytotoxic activity at a 
concentration of 100 μg/mL (12). In a study conducted 
by Ping et al. at 2013, the extract of E. hirta showed 
significant toxicity against brine shrimp with an LC₅₀ 
value of 620.382 µg/mL (13). On the other hand protective 
properties are also reported from Euphorbia hirta against 
antitubercular drug-induced cytotoxicity in freshly 
isolated hepatocytes (14). So, these results indicate that 
moderate cytotoxicity of the isolated fractions has the 
value of more phytochemical consideration and isolations 
of pure compounds responsible of the observed activities.
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